Ipilimumab vs Irbesartan
Ipilimumab vs Irbesartan: Overview
This comparison examines the pharmacological differences between Ipilimumab and Irbesartan.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Irbesartan β 11-15 hours.
Chemical Properties
Molecular Formula: Irbesartan β C25H28N6O.
Molecular Weight: Irbesartan β 428.5320 g/mol.
Type: Ipilimumab β Antibody; Irbesartan β Small molecule.